Specialty chemical maker Clariant has broken ground in Cuddalore, India on a new manufacturing plant for the healthcare industry.
In December 2015, Clariant had announced plans to invest US$10 million in the plant, which will support the growing generic pharmaceutical industry in India. The investment will be implemented through Clariant’s wholly owned subsidiary in India.
The new plant will initially produce desiccant canisters and packets, which are inserted into pharmaceutical packaging to control moisture and protect the stability of the medicine during shelf life. The desiccant production area will be Clean Room Class 100,000 and certified ISO 8. It will be compliant with all relevant cGMP and US FDA standards.
Clariant already has ten production sites in India: in Gujarat, Maharashtra, Madhya Pradesh and Tamil Nadu, and a state-of-the-art Regional Innovation Center in Mumbai.
The plant is slated for inauguration in 2017, Clariant said.
From left: Deepak Parikh, Region President India, Christian Kohlpaintner, Member of Clariant’s Executive Committee, along with Marco Cenisio, Business Unit Head Masterbatches, and Ketan Premani, Head Clariant Healthcare Packaging Sales, India, performed the groundbreaking ceremony.
